34 Movements in equity Retained earnings and other reserves amounted to 3,066 million at 31 December 2013 2012 2,429 million: 2011 4,959 million of which 307 million 2012 372 million: 2011 421 million relates to joint ventures and associated undertakings.
The cumulative translation exchange in equity is as follows: Net translation exchange included in: Total Retained Nontranslation earnings Fair value controlling exchange restated reserve interests restated m m m m At 1 January 2011 1,309 11 24 1,296 Exchange movements on overseas net assets 259 4 44 299 Reclassification of exchange on liquidation of overseas subsidiary 1 1 At 31 December 2011 1,049 15 68 996 Exchange movements on overseas net assets 203 23 30 256 At 31 December 2012 846 8 98 740 Exchange movements on overseas net assets 260 5 35 290 At 31 December 2013 586 3 133 450 The analysis of other comprehensive income by equity category is as follows: NonRetained Other controlling earnings reserves interests Total 2013 m m m m Items that may be subsequently reclassified to income statement: Exchange movements on overseas net assets and net investment hedges 260 5 255 Fair value movements on available-for-sale investments 367 367 Deferred tax on fair value movements on available-for-sale investments 29 29 Reclassification of fair value movements on available-for-sale investments 38 38 Deferred tax on reclassification of fair value movements on available-for-sale investments 7 7 Reclassification of cash flow hedges to income statement 2 2 Fair value movements on cash flow hedges 9 9 Deferred tax on fair value movements on cash flow hedges 1 1 Share of other comprehensive income of associates and joint ventures 15 15 Items that will not be reclassified to income statement: Exchange movements on overseas net assets of non-controlling interests 35 35 Actuarial gains on defined benefit plans 847 847 Deferred tax on actuarial movements in defined benefit plans 286 286 Other comprehensive income expense for the year 316 306 35 587 Retained Nonearnings Other controlling Total restated reserves interests restated 2012 m m m m Items that may be subsequently reclassified to income statement: Exchange movements on overseas net assets and net investment hedges 203 23 226 Fair value movements on available-for-sale investments 77 77 Deferred tax on fair value movements on available-for-sale investments 10 10 Reclassification of fair value movements on available-for-sale investments 19 19 Deferred tax on reclassification of fair value movements on available-for-sale investments 10 10 Reclassification of cash flow hedges to income statement 2 2 Fair value movements on cash flow hedges 6 6 Share of other comprehensive income of associates and joint ventures 30 30 Items that will not be reclassified to income statement: Exchange movements on overseas net assets of non-controlling interests 30 30 Actuarial losses on defined benefit plans 685 685 Deferred tax on actuarial movements in defined benefit plans 193 193 Other comprehensive expense income for the year 665 31 30 664 GSK Annual Report 2013 177 Financial statements Notes to the financial statements 34 Movements in equity continued Retained Nonearnings Other controlling Total restated reserves interests restated 2011 m m m m Items that may be subsequently reclassified to income statement: Exchange movements on overseas net assets and net investment hedges 259 4 255 Reclassification of exchange on liquidation or disposal of overseas subsidiaries 1 1 Fair value movements on available-for-sale investments 20 20 Deferred tax on fair value movements on available-for-sale investments 23 23 Reclassification of fair value movements on available-for-sale investments 29 29 Reclassification of cash flow hedges to income statement 1 1 Share of other comprehensive expense of associates and joint ventures 8 8 Items that will not be reclassified to income statement: Exchange movement on overseas net assets of non-controlling interests 44 44 Actuarial losses on defined benefit plans 884 884 Deferred tax on actuarial movements in defined benefit plans 243 243 Other comprehensive expense for the year 909 21 44 974 The analysis of other reserves is as follows: ESOP Trust Fair value Cash flow Other shares reserve hedge reserve reserves Total m m m m m At 1 January 2011 845 89 4 2,022 1,262 Transferred to income and expense in the year on disposals 10 3 7 Transferred to income and expense in the year on impairment 19 19 Net fair value movement in the year 10 5 5 Ordinary Shares purchased and cancelled 36 36 Ordinary Shares acquired by ESOP Trusts 36 36 Ordinary Shares transferred by ESOP Trusts 44 44 Write-down of shares held by ESOP Trusts 345 345 Forward contract on non-controlling interest 28 28 At 31 December 2011 492 70 6 2,030 1,602 Transferred to income and expense in the year on disposals 18 2 16 Transferred to income and expense in the year on impairment 1 1 Net fair value movement in the year 54 6 48 Ordinary Shares purchased and cancelled 45 45 Ordinary Shares acquired by ESOP Trusts 37 37 Ordinary Shares transferred by ESOP Trusts 58 58 Write-down of shares held by ESOP Trusts 80 80 Forward contract on non-controlling interest 8 8 At 31 December 2012 391 105 10 2,083 1,787 Transferred to income and expense in the year on disposals 38 2 36 Transferred to income and expense in the year on impairment 1 1 Net fair value movement in the year 347 4 343 Ordinary Shares purchased and cancelled 25 25 Ordinary Shares acquired by ESOP Trusts 45 45 Write-down of shares held by ESOP Trusts 80 80 At 31 December 2013 356 413 12 2,108 2,153 Other reserves include various non-distributable merger and pre-merger reserves amounting to 1,849 million at 31 December 2013 2012 1,849 million: 2011 1,849 million.
Other reserves also include the capital redemption reserve created as a result of the share buy-back programme amounting to 280 million at 31 December 2013 2012 256 million: 2011 211 million.
